Tuesday, 01 November 2016 00:33

Drug Product Development in Immune-Mediated Renal Diseases: Regulatory Perspective

By  Larissa Lapteva
Rate this item
(0 votes)

This presentation was given by Larissa Lapteva from the Center for Dug Evaluation and Research, Food and Drug Administration, USA. It was presented at the ISN Nexus Symposium held April 14-17, 2016 whose theme was “Translational Immunology in Nephrology”. It was given during Session 7: Designing Clinical Trials in Kidney Disease.

 

Additional Info

  • Language: English
  • Contains Audio: Yes
  • Content Type: Presentations
  • Source: ISN
  • Event: Nexus
  • Year: 2016
  • Members Only: No
Read 1128 times

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact